| NCT ID | NCT07597603 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dream Video LLC |
| Condition | Memory Encoding |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2027-07 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2027-07 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
H22 - Unconscious Mind Training and Memory Encoding Phase I The core problem this clinical trial, H22, seeks to address is the pervasive challenge of modifying deeply ingrained, often unconscious, unwanted behaviors within the general population. Many individuals struggle with habits or actions that negatively impact quality of life, productivity, or well-being, yet conventional methods often fall short due to the unconscious nature of these behaviors. Specifically, the trial aims to investigate the efficacy of H22, a novel intervention designed to engage and train the unconscious mind, in mitigating these unwanted behaviors. The central hypothesis guiding this research is that H22 training will empower volunteers to significantly reduce the frequency and intensity of identified unwanted behaviors.
Eligibility Criteria
Inclusion Criteria: * Can read and write * Willing and able to follow the requirements of the protocol Exclusion Criteria: \- Medical instability, restlessness, or other factors that would compromise data acquisition
Contact & Investigator
Matthew Quitto II
STUDY DIRECTOR
Dream Video LLC
Frequently Asked Questions
Who can join the NCT07597603 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 75 Years, studying Memory Encoding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07597603 currently recruiting?
Yes, NCT07597603 is actively recruiting participants. Contact the research team at dream@dreamholdingsllc.com for enrollment information.
Where is the NCT07597603 trial being conducted?
This trial is being conducted at Naples, United States.
Who is sponsoring the NCT07597603 clinical trial?
NCT07597603 is sponsored by Dream Video LLC. The principal investigator is Matthew Quitto II at Dream Video LLC. The trial plans to enroll 100 participants.